D'ORAZI, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 7.433
AS - Asia 5.939
EU - Europa 4.923
SA - Sud America 1.130
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
Totale 19.526
Nazione #
US - Stati Uniti d'America 7.304
SG - Singapore 2.322
CN - Cina 1.593
BR - Brasile 953
UA - Ucraina 874
IE - Irlanda 805
TR - Turchia 728
RU - Federazione Russa 726
VN - Vietnam 668
IT - Italia 569
DE - Germania 564
GB - Regno Unito 412
SE - Svezia 407
FR - Francia 230
IN - India 194
FI - Finlandia 184
BD - Bangladesh 98
HK - Hong Kong 78
AR - Argentina 68
CA - Canada 59
ID - Indonesia 43
JP - Giappone 42
EC - Ecuador 41
MX - Messico 40
NL - Olanda 30
ZA - Sudafrica 28
IQ - Iraq 26
AT - Austria 22
PK - Pakistan 21
BE - Belgio 20
PL - Polonia 19
KR - Corea 17
ES - Italia 16
CO - Colombia 15
PY - Paraguay 15
MA - Marocco 14
SA - Arabia Saudita 14
TN - Tunisia 14
PH - Filippine 11
UZ - Uzbekistan 11
VE - Venezuela 11
CL - Cile 10
IL - Israele 10
LT - Lituania 8
AZ - Azerbaigian 7
EU - Europa 7
JO - Giordania 7
KE - Kenya 7
PE - Perù 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
SN - Senegal 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
IR - Iran 5
KZ - Kazakistan 5
AU - Australia 4
CZ - Repubblica Ceca 4
GT - Guatemala 4
KG - Kirghizistan 4
MY - Malesia 4
NG - Nigeria 4
RO - Romania 4
TH - Thailandia 4
BH - Bahrain 3
CR - Costa Rica 3
DK - Danimarca 3
EG - Egitto 3
JM - Giamaica 3
KW - Kuwait 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
AL - Albania 2
AO - Angola 2
BG - Bulgaria 2
EE - Estonia 2
HN - Honduras 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
FJ - Figi 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 19.516
Città #
Singapore 1.594
Jacksonville 1.072
San Jose 1.005
Dublin 799
Chandler 690
Ashburn 479
Princeton 416
Dallas 379
Izmir 359
Beijing 324
Nanjing 320
Southend 308
Wilmington 216
Ho Chi Minh City 214
Council Bluffs 202
Santa Clara 188
Cambridge 171
Los Angeles 161
Tongling 141
Ann Arbor 135
Hanoi 132
Altamura 122
Nanchang 119
Dearborn 113
Moscow 103
The Dalles 96
Buffalo 93
Chieti 91
Grevenbroich 90
New York 80
Woodbridge 80
São Paulo 78
Dong Ket 68
Hong Kong 68
Redondo Beach 64
Rome 60
Grafing 57
Kunming 52
Shenyang 48
Hebei 42
Boardman 41
Tianjin 39
Nuremberg 36
Tokyo 35
Washington 34
Jiaxing 33
Norwalk 33
Hefei 31
Changsha 27
Chicago 27
Haiphong 27
Orem 25
Chennai 23
Da Nang 23
Rio de Janeiro 23
Hangzhou 22
Brooklyn 20
Frankfurt am Main 20
Houston 20
Seattle 20
Brasília 19
Brussels 19
Jinan 19
Milan 19
Montreal 18
Belo Horizonte 17
Guayaquil 17
Mexico City 16
Pescara 16
Stockholm 16
Denver 15
London 15
Toronto 15
Hải Dương 14
Lappeenranta 14
Phoenix 14
Salvador 14
San Francisco 14
Campinas 13
Changchun 13
Falls Church 13
Guarulhos 13
Jakarta 13
Warsaw 13
Atlanta 12
Bologna 12
Dhaka 12
Porto Alegre 12
Seoul 12
Amsterdam 11
Biên Hòa 11
Curitiba 11
Fortaleza 11
Johannesburg 11
Lanzhou 11
Ninh Bình 11
Tashkent 11
Zhengzhou 11
Ankara 10
Manchester 10
Totale 11.936
Nome #
Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression 192
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies 160
A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells 148
Hyperglycemia triggers HIPK2 protein degradation 146
Wild-type p53-mediated down-modulation of IL-15 and IL-15 receptors in human rhabdomyosarcoma cells. 138
HIPK2 role in the tumor-host interaction: Impact on fibroblasts transdifferentiation CAF-like 136
Xenotransplantion in immunodepressed nude mice of human solid tumors and acute leukemias directly from patients or in vitro cell lines. 135
Activation of p53/p21waf1 pathway is associated with senescence during v-Ha-ras transformation of immortal C2C12 myoblasts. 134
Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death 133
Zn(II)-curc targets p53 in thyroid cancer cells 132
Aspetti differenziativi in una coltura di cellule dell'epitelio intestinale e sintesi di matrice extracellulare 131
Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells 129
HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function 127
Sep corticali e midollari nel ratto dopo trauma spinale 126
Azurin modulates the association of Mdm2 with p53: SPR evidence from interaction of the full-length proteins. 126
Analysis of MMP-2 and MMP-9 activity in prostate fluids, tissue homogenates and primary cell culture from patients with prostate cancer or benign prostate disease 125
P53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions 125
Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting. 125
Reactivation of mutant p53 by capsaicin, the major constituent of peppers 124
Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells. 123
Aspetti ultastrutturali di lingua e paradenzio di ratti alimentati con dieta aproteica 120
The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cells 119
Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells. 118
Aspetti differenziativi in una coltura di cellule dell'epitelio intestinale e sintesi di matrice extracellulare 118
Autophagy manipulation as a strategy for efficient anticancer therapies: Possible consequences 118
Homeodomain-interacting protein kinase 2 phosphorylates p53 at Ser46 and mediates apoptosis 117
p53 reactivation: The link to zinc 117
Follicle-stimulating hormone increases the expression of tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 and induces TIMP-1 AP-1 site binding complex(es) in prepubertal rat Sertoli cells 114
Activation of p53-dependent apoptosis in HIPK2 depleted tumor cells: an approach of combination therapy with drug, zinc, and deacetylase inhibitors 114
HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma 114
Interplay between endoplasmic reticulum (ER) stress and autophagy induces mutant p53H273 degradation 113
Studio ultrastrutturale ed immunoelettromicroscopico dello stroma desmoplastico nel carcinoma della mammella. 112
HIPK2 regulates beta-catenin level and transcriptional potential 112
Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. 112
Zinc supplementation to chemotherapy of tumor cells restores p53 and HIPK2 activities, chemosensitivity and reduces tumor growth 111
Analysis of type V collagen as a component of breast carcinoma desmoplastic stroma 111
Clearing mutant p53 with natural compounds: implication for anticancer therapeutical approaches 111
Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function. 110
A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status 109
HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA. 108
HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. 107
Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo. 107
Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis 106
Mutant P53, stabilized by its interplay with HSP90, activates a positive feed-back loop between NRF2 and P62 that induces chemo-resistance to apigenin in pancreatic cancer cells 106
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis 106
Cisti odontogene dei mascellari: aspetti ultrastrutturali dello stroma 105
The 72-kDa and the 92-kDa gelatinases, but not their inhibitors TIMP-1 and TIMP-2, are expressed in early psoriatic lesions. 105
Functional role of the HIPK2/p53 interaction in differentiation and development 105
Abrogation of p53 activity by HIPK2 down-regulation 105
PBA preferentially impairs cell survival of glioblastomas carrying mutp53 by reducing its expression level, stabilizing wtp53, downregulating the mevalonate kinase and dysregulating UPR 105
Considerazioni clinico-prognostiche sui tumori carcinoidi dell’ileo 104
Homeodomain-interacting protein kinase-2 restrains cytosolic phospholipase A2-dependent prostaglandin E2 generation in human colorectal cancer cells. 104
Ciclo cellulare e radiazioni 104
Studio della matrice extracellulare come marker tumorale 103
Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha. 103
Zinc supplementation counteracts cobalt-induced inhibition of homeodomain-interacting protein kinase-2 (HIPK2) and restores tumor chemosensitivity and p53 apoptotic function 103
JNK and macroautophagy activation by Bortezomib has a pro-survival effect in Primary Effusion Lymphoma cells 103
Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells 103
Ruolo della fibronectina (FN) nell'interazione NK-cellula bersaglio 102
Expression and synthesis of fibronectin and laminin by an intestinal epithelial cell line 102
Wt-p53 has suppressor activity only in fully transformed cells 102
Laminin synthesis by rat NK cells and T lymphocytes 102
Etiologia delle lesioni papillari vescicali: nota preliminare 101
Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival. 101
A novel Zn(II)-compound reactivates mutant p53 protein in cancer cells: molecular mechanisms and therapeutical implications 101
HIPK2-induced p53Ser46 phosphorylation activates the KILLER/DR5-mediated caspase-8 extrinsic apoptotic pathway. 100
Zinc supplementation to cancer cells counteracts hypoxia-induced inhibition of HIPK2, suppresses HIF-1alpha activity and restores p53Ser46-dependent drug response 100
Blockade of HIPK2 apoptotic function is involved in chemoresistance to cisplatin in ovarian cancer cells 100
p53 can inhibit cell proliferation through caspase-mediated cleavage of ERK2/MAPK. 99
Combination therapy strategies in HIPK2 knockdown tumor cells require Sirt1 inhibitor to activate p53 apoptotic transcription 99
Updates on HIPK2: a resourceful oncosuppressor for clearing cancer 99
Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc. 99
Nobel committee honors tumor immunologists 99
Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response 99
Ultrastructurale evidence of the mechanism responsible for Interleukin-4 activated rejection of a spontaneous murine adenocarcinoma. 99
Laminin production by Natural Killer cells 98
Zinco come adiuvante nelle chemioterapie per la riattivazione del pathway oncosoppressorio HIPK2/p53 98
Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells 98
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 98
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions 98
Modulation of laminin synthesis in human neuroblastoma cells during retinoic acid induced differentiation. 97
Exogenous wt-p53 expression is not detrimental for normal cells: implications for tumor gene therapy 97
Aspetti ultrastrutturali ed immunochimici della componente vasale del timo in condizioni normali e patologiche 97
Quercetin Interrupts the Positive Feedback Loop Between STAT3 and IL-6, Promotes Autophagy, and Reduces ROS, Preventing EBV-Driven B Cell Immortalization 97
Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53 96
Exogenous wt-p53 is stable and transcriptionally active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting 96
Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1 96
New Copper-Based Metallodrugs with Anti-Invasive Capacity 95
Hypoxia-inducible factor -1 (HIF-1) antagonizes p53-mediated apoptosis 95
P53 can inhibit cell proliferation through caspase-mediated cleavage of ERK/MAPK 95
Sintesi di laminina da parte delle cellule NK e dei linfociti T di ratto 95
P53 activity in normal and tumor cells 95
High glucose and hyperglycemic sera from type 2 diabetic patients impair DC differentiation by inducing ROS and activating Wnt/β-catenin and p38 MAPK 95
Chloroquine supplementation increases the cytotoxic effect of curcumin against Her2/neu overexpressing breast cancer cells in vitro and in vivo in nude mice while counteracts it in immune competent mice 95
Targeting mutant p53 in cancer: the latest insights 95
Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link? 94
Chronic damage after spinal trauma in rat: neurophysiological and ultrastructural investigations. 94
Il trasferimento genico di p53 induce iper-sensibilita‚ alle basse dosi di raggi X in cellule di glioblastoma: una nuova strategia per convertire il fenotipo radio-resistente in radio-sensibile 94
Rat natural killer cells synthesize fibronectin: possible involvement in the cytotoxic function. 93
Tumor cell response to cisplatin requires HIPK2 and p53 phosphorylation at ser46 93
Totale 10.975
Categoria #
all - tutte 85.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 0 0 0 0 0 0 101
2021/2022828 6 6 4 48 80 68 22 70 68 20 111 325
2022/20232.223 275 353 178 216 130 475 179 126 186 25 50 30
2023/2024977 62 36 70 33 52 280 264 52 6 38 14 70
2024/20252.947 289 517 331 65 37 106 44 154 395 132 243 634
2025/20266.972 438 251 905 1.265 440 284 968 400 761 640 375 245
Totale 20.473